Previous research has demonstrated that luteolin can inhibit cancer cell proliferation, migration, and invasion through multiple pathways, including the JAK/STAT pathway and the PI3K/AKT pathway (Singh Tuli et al., 2022). Here, AKT1 is linked to cancer.